Luhong Sun

1.0k total citations
19 papers, 564 citations indexed

About

Luhong Sun is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Luhong Sun has authored 19 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Luhong Sun's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Ubiquitin and proteasome pathways (6 papers). Luhong Sun is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Ubiquitin and proteasome pathways (6 papers). Luhong Sun collaborates with scholars based in United States, China and India. Luhong Sun's co-authors include Michael Wang, Qing Yi, Huaqing Wang, Zhen Cai, Liang Zhang, Long Yu, J. Blake Bartlett, Liang Zhang, Zhengzi Qian and Lin Xu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Luhong Sun

19 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luhong Sun United States 10 286 213 207 146 127 19 564
Antonia Rodríguez Spain 10 269 0.9× 179 0.8× 284 1.4× 204 1.4× 99 0.8× 14 595
Heather Bendall United States 8 244 0.9× 170 0.8× 184 0.9× 161 1.1× 182 1.4× 14 628
Madlene Oelsner Germany 10 373 1.3× 190 0.9× 135 0.7× 214 1.5× 189 1.5× 11 667
Kedar Inamdar United States 15 393 1.4× 253 1.2× 276 1.3× 156 1.1× 141 1.1× 39 772
Scott A. Ezell United States 10 339 1.2× 146 0.7× 121 0.6× 89 0.6× 76 0.6× 11 552
Kamlai Saiya-Cork United States 11 191 0.7× 124 0.6× 222 1.1× 201 1.4× 131 1.0× 15 480
Shruti Bhatt United States 14 261 0.9× 274 1.3× 190 0.9× 118 0.8× 139 1.1× 37 658
Matthew D. Blunt United Kingdom 14 260 0.9× 151 0.7× 104 0.5× 179 1.2× 281 2.2× 31 606
Geoffrey Shouse United States 14 387 1.4× 328 1.5× 139 0.7× 73 0.5× 73 0.6× 71 664
Paul Glover United States 13 250 0.9× 230 1.1× 264 1.3× 161 1.1× 95 0.7× 17 634

Countries citing papers authored by Luhong Sun

Since Specialization
Citations

This map shows the geographic impact of Luhong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luhong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luhong Sun more than expected).

Fields of papers citing papers by Luhong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luhong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luhong Sun. The network helps show where Luhong Sun may publish in the future.

Co-authorship network of co-authors of Luhong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Luhong Sun. A scholar is included among the top collaborators of Luhong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luhong Sun. Luhong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Havránek, Ondřej, Jingda Xu, Stefan Köhrer, et al.. (2017). Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 130(8). 995–1006. 66 indexed citations
2.
Havránek, Ondřej, Stefan Koehrer, Zhiqiang Wang, et al.. (2014). The B-Cell Receptor Is Required for Optimal Viability, Growth, and Chemotherapy Resistance of Diffuse Large B-Cell Lymphoma Cell Lines of the Germinal Center B-Cell Subtype. Blood. 124(21). 493–493. 3 indexed citations
3.
Park, H., Luhong Sun, Izabela Fokt, et al.. (2014). Potent Inhibition of the Growth and Induction of Apoptosis of Mantle Cell Lymphoma By the Novel Anthracycline Berubicin in Vitro and in Vivo. Blood. 124(21). 3106–3106. 1 indexed citations
4.
Zhang, Liang, Lan V. Pham, Kate J. Newberry, et al.. (2013). In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome. Molecular Cancer Therapeutics. 12(11). 2494–2504. 22 indexed citations
6.
Wang, Michael, Archito T. Tamayo, Sharon Shacham, et al.. (2012). Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma. Experimental Hematology. 41(1). 67–78.e4. 82 indexed citations
7.
Pham, Lan V., Archito T. Tamayo, J. Jack Lee, et al.. (2012). Biological Significance of the Immumoproteasome Subunits Mecl-1 and LMP-2 in Diffuse Large B-Cell Lymphoma.. Blood. 120(21). 2717–2717. 1 indexed citations
8.
Wang, Lijuan, Yi Zhao, Jianfei Qian, et al.. (2012). Toll‐like receptor‐4 signaling in mantle cell lymphoma. Cancer. 119(4). 782–791. 42 indexed citations
9.
Wang, Michael, Luhong Sun, Izabela Fokt, et al.. (2012). Effect of berubicin, the 4'-o-benzylated doxorubicin analog, on growth inhibition and apoptosis in multiple myeloma.. Journal of Clinical Oncology. 30(15_suppl). e18557–e18557. 3 indexed citations
10.
Sun, Luhong, Liang Zhang, Jianfei Qian, et al.. (2011). Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo. Leukemia Research. 36(3). 363–368. 5 indexed citations
11.
Zhang, Liang, Jianfei Qian, Zhishuo Ou, et al.. (2011). Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,. Blood. 118(21). 3740–3740. 2 indexed citations
13.
Ma, Wencai, Michael Wang, Zhiqiang Wang, et al.. (2010). Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling. Cancer Epidemiology Biomarkers & Prevention. 19(10). 2445–2452. 35 indexed citations
14.
Qian, Zhengzi, Liang Zhang, Luhong Sun, et al.. (2010). Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo. Leukemia Research. 35(3). 380–386. 53 indexed citations
15.
Zhang, Liang, Zhengzi Qian, Zhen Cai, et al.. (2009). Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo. American Journal of Hematology. 84(9). 553–559. 120 indexed citations
16.
Qian, Jianfei, Sungyoul Hong, Siqing Wang, et al.. (2009). Myeloma cell line–derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma. Blood. 114(18). 3880–3889. 26 indexed citations
17.
Zhu, Na, Yan Shao, Lin Xu, Long Yu, & Luhong Sun. (2008). Gadd45-α and Gadd45-γ utilize p38 and JNK signaling pathways to induce cell cycle G2/M arrest in Hep-G2 hepatoma cells. Molecular Biology Reports. 36(8). 2075–2085. 59 indexed citations
18.
Sun, Luhong, Ruomu Gong, Bo Wan, et al.. (2003). GADD45γ, down-regulated in 65% Hepatocellular Carcinoma (HCC) from 23 Chinese patients, inhibits cell growth and induces cell cycle G2/M arrest for Hepatoma Hep-G2 cell lines. Molecular Biology Reports. 30(4). 249–253. 34 indexed citations
19.
Ji, Xiaohui, et al.. (2000). Effects of rhM-CSF expressed in silkworm on cytokine productions and membrane molecule expressions of human monocytes.. PubMed. 21(9). 797–801. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026